Nkarta
Price & Volume
Stats
See more52W Range | $1.31-$2.74 |
Market Cap | $134.9M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $385 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$36.2M |
Diluted EPS | -$1.38 |
News
See moreYahoo Finance • last month
Nkarta to Participate in Evercore Healthcare Conference
Yahoo Finance • 2 months ago
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
Yahoo Finance • 2 months ago
Nkarta to Participate in November Investor Conferences
Yahoo Finance • 3 months ago
Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies | DelveInsight
About
CEO | Mr. Paul J. Hastings |
Address | 1150 Veterans Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 105 |
